Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

This study has been completed.
Sponsor:
Collaborators:
HIV Vaccine Trials Network
Information provided by (Responsible Party):
AlphaVax, Inc.
ClinicalTrials.gov Identifier:
NCT00097838
First received: November 30, 2004
Last updated: June 27, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
No publications provided by AlphaVax, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):